Fundamental Analysis
59 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +221.5% | +126.3% | 3 / 3 | +46.2% | +0.13 pp | +1.08 pp | +3.3% | 1.86 | 27.05 | 1.793 | +46,2% | 8,8 | +221,5% | 27.05 | 0.54 | +4.909,2% |
| Pts | 12 | 12 | 12 | 12 | 8 | 8 | 0 | -4 | 4 | |||||||
Valuation annotation:Price: 16.800 (close price on 2026-10-19)EPS (TTM): 621,1
Financial charts
1.Revenue & growth
VND bn1.793Q2/26
1.Revenue & growth
VND bn1.793Q2/26
2.Profit & growth
VND bn8,75Q2/26
3.Profit mix (Penman)
VND bn36,8Q2/26
4.Margins & cost structure
%3.7%Q2/26
5.Returns & cash cycle
% · days4.8%Q2/26
6.Earnings quality & cash
VND bn369Q2/26
7.Asset structure
VND bn3.370Q2/26
8.Funding & debt health
VND bn · times3.370Q2/26
9.Revenue backlog
VND bn0,36Q2/26
10.Valuation
times · %27,0×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %175Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
34.2%
averaged over 1 quarter(s)
Quarters at 25%+ growth
3/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26